Teen Vaccine Approvals Increasing, FDA Says
This article was originally published in The Pink Sheet Daily
Executive Summary
The agency is observing a rise in the number of vaccines targeted at adolescents, CBER Vaccine Research & Review Director Baylor says. Two vaccines for use in adolescents – Menactra and Boostrix – have been approved so far this year; a third, Adacel, has a user fee date of June 11.